DexCom, Inc. DexCom, Inc.

DexCom, Inc.

DXCM

Kedudukan dalam Saham #755
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Harga Saham
$86.01
Modal Pasaran
$32.45B
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
29.14%
Negara
US
Perdagangan DexCom, Inc. (DXCM)

Kategori

Healthcare
Sejarah dividen untuk DexCom, Inc. (DXCM)
DexCom, Inc. (simbol saham: DXCM) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk DexCom, Inc. (DXCM) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
Tidak cukup data untuk tarikh yang disediakan.
Senarai semua pembayaran dividen
Tahun Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
173.00%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
178.00%
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
85.00%
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00%
DE